Pharmacokinetic and Pharmacodynamic Profile of Rosuvastatin in Patients with End-Stage Renal Disease on Chronic Haemodialysis

被引：0
|
作者：
Bruce K. Birmingham
Suzanne K. Swan
Tom Puchalski
Pat Mitchell
Connie Azumaya
Julie Zalikowski
Yi Wang
机构：
[1] AstraZeneca,
[2] DaVita Clinical Research & Hennepin County Medical Center,undefined
[3] Purdue Pharma,undefined
[4] One Stamford Forum,undefined
来源：
Clinical Drug Investigation | 2013年 / 33卷
关键词：
Rosuvastatin; ESRD Patient; Severe Renal Impairment; Chronic Haemodialysis; ISTD;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：233 / 241
页数：8
相关论文
共 50 条
  • [1] Pharmacokinetic and Pharmacodynamic Profile of Rosuvastatin in Patients with End-Stage Renal Disease on Chronic Haemodialysis
    Birmingham, Bruce K.
    Swan, Suzanne K.
    Puchalski, Tom
    Mitchell, Pat
    Azumaya, Connie
    Zalikowski, Julie
    Wang, Yi
    CLINICAL DRUG INVESTIGATION, 2013, 33 (04) : 233 - 241
  • [2] Removal of clodronate by haemodialysis in end-stage renal disease patients
    Beigel, AE
    Rienhoff, E
    Olbricht, CJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (12) : 2266 - 2268
  • [3] The pharmacokinetics of etanercept in patients with end-stage renal disease on haemodialysis
    Don, BR
    Spin, G
    Nestorov, I
    Hutmacher, M
    Rose, A
    Kaysen, GA
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 (11) : 1407 - 1413
  • [4] Quality of life of patients on haemodialysis for end-stage renal disease
    Cleary, J
    Drennan, J
    JOURNAL OF ADVANCED NURSING, 2005, 51 (06) : 577 - 586
  • [5] INFLAMMATORY MARKERS IN END-STAGE RENAL DISEASE PATIENTS ON HAEMODIALYSIS
    Abdel-Messeih, Phebe Lotfy
    Alkady, Manal Mohamed
    Nosseir, Neveen Mostafa
    Tawfik, Mohamed Said
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2020, 39 (04) : 481 - 487
  • [6] Frailty in Older Patients with End-Stage Renal Disease and Undergoing Chronic Haemodialysis in Vietnam
    Nguyen, Tan Van
    Pham, Thu Thi Xuan
    Burns, Mason Jenner
    Nguyen, Tu Ngoc
    DIABETOLOGY, 2023, 4 (03): : 312 - 322
  • [7] Gentamicin dosing strategy in patients with end-stage renal disease receiving haemodialysis: evaluation using a semi-mechanistic pharmacokinetic/pharmacodynamic model
    Zhuang, Luning
    He, Yang
    Xia, Huiming
    Liu, Yajun
    Sy, Sherwin K. B.
    Derendorf, Hartmut
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (04) : 1012 - 1021
  • [8] Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis
    Bianchi, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 : 105 - 110
  • [9] Calcium-channel blockers and end-stage renal disease: pharmacokinetic and pharmacodynamic considerations
    Sica, DA
    Gehr, TWB
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2003, 12 (02): : 123 - 131
  • [10] Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis
    Fukuta, H
    Hayano, J
    Ishihara, S
    Sakata, S
    Mukai, S
    Ohte, N
    Ojika, K
    Yagi, K
    Matsumoto, H
    Sohmiya, S
    Kimura, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (02) : 318 - 325
12345